Some stem cell clinics pose threat to patients seeking AMD treatment

Patients interested in stem cell therapy for ophthalmic issues should take precautions to find clinics that are licensed, are associated with an academic center, have a history of running clinical trials and do not require patients to pay out of pocket.Three patients with bilateral vision loss after bilateral intravitreal injection of stem cells for age-related macular degeneration at the same stem cell clinic reported to Bascom Palmer Eye Institute and Dean McGee Eye Institute with serious complications after their procedures, Ajay E. Kuriyan, MD, MS, told Ocular Surgery News.

Full Story →